Stay updated on Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial

Sign up to get notified when there's something new on the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page’s displayed site revision/version number was updated from v3.5.2 to v3.5.3. This reflects a site release change rather than any update to the study’s results or details.
    Difference
    0.1%
    Check dated 2026-04-24T05:56:17.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:29:15.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T04:49:31.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:15:34.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; notice about government funding lapse was removed and Revision: v3.4.1 was deleted. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-11T14:42:09.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    A site-wide notice about government funding was added and release notes were updated to revision v3.4.1. The previous note for v3.4.0 was removed.
    Difference
    1.0%
    Check dated 2026-02-04T10:42:45.000Z thumbnail image

Stay in the know with updates to Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page.